Zepp Health Corporation Sponsored ADR ZEPP
4.14
0.02
0.49%
as of 25 Sep
- Market cap
- $34.9M
- P/E
- 0.0×
Follow ZEPP
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(24.35%) | (17.15%) | (18.76%) | (21.23%) | |
| (11.23%) | (7.33%) | (7.60%) | (7.86%) | ||
ROIC |
(9.25%) | (8.43%) | (8.18%) | (10.25%) | |
Return on Tangible Assets |
(208.31%) | (324.62%) | 135.69% | 164.91% | |
Average Days of Receivables |
136.43 | 103.73 | 83.77 | 109.21 | |
Free Cash Flow per Share |
0.00 | (7.55) | 0.00 | 0.00 | |
Free Cash Flow |
— | (119.99) | — | — | |
Capital Expenditures |
— | 1.69 | — | — | |
Piotroski F-Score |
— | 1.00 | — | — | |
| Other line items | |||||
Cash ROIC |
0.00% | (27.49%) | 0.00% | 0.00% | |
Accounts Receivable Turnover |
3.52 | 3.72 | 4.61 | 3.51 | |
Accounts Payable Turnover |
2.14 | 2.42 | 2.79 | 1.94 | |
Inventory Turnover |
1.78 | 2.47 | 2.64 | 2.38 | |
Average Days of Payables |
261.65 | 184.59 | 128.98 | 189.43 | |
Days of Inventory on Hand |
218.34 | 166.28 | 136.82 | 134.43 | |
Tax Rate |
0.29 | 0.07 | 0.08 | 0.07 | |
Research and Development Expense of Revenue |
19.46% | 17.50% | 16.95% | 16.83% | |
Selling, General and Administrative Expense of Revenue |
32.41% | 32.10% | 31.90% | 34.34% | |
Share Based Compensation of Revenue |
0.00% | 8.95% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 3.04 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
0.00 | 4.55 | 0.00 | 0.00 | |
Capex/Depreciation |
— | 0.07 | — | — | |
Revenue per Share |
14.75 | 16.28 | 17.13 | 17.43 | |
Operating CF per Share |
0.00 | (7.65) | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.11 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | (0.01) | 0.00 | 0.00 | |
Net Profit Margin |
(28.28%) | (15.48%) | (14.70%) | (15.78%) |
Columns are period end dates